Home › FDA Approves Merck's HPV Vaccine, GARDASIL9, to Prevent Cancers and Other Diseases Caused by Nine HPV types Including Types that Cause About 90% of Cervical Cancer Cases
 

Keywords :   


FDA Approves Merck's HPV Vaccine, GARDASIL9, to Prevent Cancers and Other Diseases Caused by Nine HPV types Including Types that Cause About 90% of Cervical Cancer Cases

2014-12-11 23:30:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. GARDASIL 9 includes the greatest number of HPV types in any available HPV vaccine KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Deb Wambold, 215-652-2913orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: of that including types

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
22.05Eastern North Pacific Tropical Weather Outlook
22.05Atlantic Tropical Weather Outlook
22.05UK watchdog looking into Microsoft AI taking screenshots
21.05Clarins Begins Testing Generative AI-powered Customer Care Bot in US
21.05Waldencast Reports $68.3 Million in Net Revenue in Q1 2024
21.05Pixalate releases April 2024 top grossing CTV apps report
21.05A+E Networks EMEA enhances BLAZE streaming service with Simplestream
21.05Minerva unveils FAST+ Service for operators in North America
More »